Fibroblast-derived HSD11B1 deficiency drives lung cancer in never-smokers through steroid metabolic imbalance
Zesen Luo, Haitang Yang, Jiaying Jia, Hao Zhang, Feng Yao · 2026
Read Fibroblast-derived HSD11B1 deficiency drives lung cancer in never-smokers through steroid metabolic imbalance by Zesen Luo, Haitang Yang, Jiaying Jia, Hao Zhang, Feng Yao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13444321.txt.
Description
Lung cancer in people who never smoked behaves differently from the smoker's disease, and its triggers are largely unknown. Zesen Luo, Haitang Yang, Jiaying Jia, Hao Zhang, and Feng Yao traced one trigger in 2026 to the support cells around the tumor. An enzyme in those fibroblasts, HSD11B1, normally keeps local steroid balance in check.
Genetic checks, single-cell profiling, and lab studies showed that losing the enzyme in fibroblasts tips the steroid mix around lung cells. That imbalance pushes normal airway cells toward cancer and speeds tumor growth, and patients with low levels fared worse. The authors name the enzyme a gatekeeper whose loss opens a non-smoking route to lung cancer.
Catalog record
| CREATOR | Zesen Luo, Haitang Yang, Jiaying Jia, Hao Zhang, Feng Yao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |